246 related articles for article (PubMed ID: 37228711)
1. Direct medical costs of ischemic heart disease in urban Southern China: a 5-year retrospective analysis of an all-payer health claims database in Guangzhou City.
Xie P; Li X; Guo F; Zhang D; Zhang H
Front Public Health; 2023; 11():1146914. PubMed ID: 37228711
[TBL] [Abstract][Full Text] [Related]
2. Direct Medical Costs of Parkinson's Disease in Southern China: A Cross-Sectional Study Based on Health Insurance Claims Data in Guangzhou City.
Zhang H; Zhou W; Zhang D
Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35328925
[TBL] [Abstract][Full Text] [Related]
3. Differences in medical costs among urban lung cancer patients with different health insurance schemes: a retrospective study.
Li Y; Yang Y; Yuan J; Huang L; Ma Y; Shi X
BMC Health Serv Res; 2022 May; 22(1):612. PubMed ID: 35524258
[TBL] [Abstract][Full Text] [Related]
4. Health care utilization for patients with stroke: a 3-year cross-sectional study of China's two urban health insurance schemes across four cities.
Yang Y; Nicholas S; Li S; Huang Z; Chen X; Ma Y; Shi X
BMC Public Health; 2021 Mar; 21(1):531. PubMed ID: 33736618
[TBL] [Abstract][Full Text] [Related]
5. Costs of Hospitalization for Dementia in Urban China: Estimates from Two Urban Health Insurance Scheme Claims Data in Guangzhou City.
Zhang H; Zhang D; Yin Y; Zhang C; Huang Y
Int J Environ Res Public Health; 2019 Aug; 16(15):. PubMed ID: 31382609
[No Abstract] [Full Text] [Related]
6. Utilisation of health services among urban patients who had an ischaemic stroke with different health insurance - a cross-sectional study in China.
Yang Y; Man X; Nicholas S; Li S; Bai Q; Huang L; Ma Y; Shi X
BMJ Open; 2020 Oct; 10(10):e040437. PubMed ID: 33040017
[TBL] [Abstract][Full Text] [Related]
7. Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China.
Zhang H; Zhang C; Zhu S; Ye H; Zhang D
BMC Health Serv Res; 2020 Feb; 20(1):122. PubMed ID: 32059726
[TBL] [Abstract][Full Text] [Related]
8. Direct medical costs for patients with schizophrenia: a 4-year cohort study from health insurance claims data in Guangzhou city, Southern China.
Zhang H; Sun Y; Zhang D; Zhang C; Chen G
Int J Ment Health Syst; 2018; 12():72. PubMed ID: 30479658
[TBL] [Abstract][Full Text] [Related]
9. Costs of hospitalization for stroke from two urban health insurance claims data in Guangzhou City, southern China.
Zhang H; Yin Y; Zhang C; Zhang D
BMC Health Serv Res; 2019 Sep; 19(1):671. PubMed ID: 31533714
[TBL] [Abstract][Full Text] [Related]
10. Disparity in reimbursement for tuberculosis care among different health insurance schemes: evidence from three counties in central China.
Pan Y; Chen S; Chen M; Zhang P; Long Q; Xiang L; Lucas H
Infect Dis Poverty; 2016 Jan; 5():7. PubMed ID: 26812914
[TBL] [Abstract][Full Text] [Related]
11. Disparities in end-of-life care, expenditures, and place of death by health insurance among cancer patients in China: a population-based, retrospective study.
Li Z; Hung P; He R; Tu X; Li X; Xu C; Lu F; Zhang P; Zhang L
BMC Public Health; 2020 Sep; 20(1):1354. PubMed ID: 32887583
[TBL] [Abstract][Full Text] [Related]
12. Medical insurance payment schemes and patient medical expenses: a cross-sectional study of lung cancer patients in urban China.
Hu H; Zhao L; Yong Y; Nicholas S; Maitland E; Zhao W; Yan H; Ma Y; Shi X
BMC Health Serv Res; 2023 Jan; 23(1):89. PubMed ID: 36703175
[TBL] [Abstract][Full Text] [Related]
13. Differences exist across insurance schemes in China post-consolidation.
Li Y; Zhao Y; Yi D; Wang X; Jiang Y; Wang Y; Liu X; Ma S
PLoS One; 2017; 12(11):e0187100. PubMed ID: 29125837
[TBL] [Abstract][Full Text] [Related]
14. Managing Urban Stroke Health Expenditures in China: Role of Payment Method and Hospital Level.
Yang Y; Man X; Yu Z; Nicholas S; Maitland E; Huang Z; Ma Y; Shi X
Int J Health Policy Manag; 2022 Dec; 11(11):2698-2706. PubMed ID: 35219287
[TBL] [Abstract][Full Text] [Related]
15. Effect of health insurance on direct hospitalisation costs for in-patients with ischaemic stroke in China.
Yong M; Xianjun X; Jinghu L; Yunyun F
Aust Health Rev; 2018 Feb; 42(1):39-44. PubMed ID: 28263706
[TBL] [Abstract][Full Text] [Related]
16. Healthcare costs for patients with rare diseases: Evidence from China.
Zhang X; Dai L; Long Y; Chen X; Alhafi MAK
Int J Health Plann Manage; 2024 Jan; 39(1):48-61. PubMed ID: 37815061
[TBL] [Abstract][Full Text] [Related]
17. Out-of-pocket cost by cancer stage at diagnosis in commercially insured patients in the United States.
McGarvey N; Gitlin M; Fadli E; Chung KC
J Med Econ; 2023; 26(1):1318-1329. PubMed ID: 37907436
[TBL] [Abstract][Full Text] [Related]
18. Inequity in healthcare needs, health service use and financial burden of medical expenditures in China: results from a consecutive household monitoring study in Jiangsu Province.
Jiang W; Xu X; Tang S; Xu L; Zhang Y; Elbers C; Cobelens F; Yan L
BMC Health Serv Res; 2019 Dec; 19(1):966. PubMed ID: 31842861
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with the healthcare expenditures of patients with multiple sclerosis in urban areas of China estimated by a generalized estimating equation.
Du Y; Min R; Zhang X; Fang P
Expert Rev Pharmacoecon Outcomes Res; 2021 Feb; 21(1):137-144. PubMed ID: 31984811
[No Abstract] [Full Text] [Related]
20. Hospitalization Expenditures and Out-Of-Pocket Expenses in Patients With Stroke in Northeast China, 2015-2017: A Pooled Cross-Sectional Study.
Ma Z; Deng G; Meng Z; Wu H
Front Pharmacol; 2020; 11():596183. PubMed ID: 33613278
[No Abstract] [Full Text] [Related]
[Next] [New Search]
